IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bios Capital Management, LP

Q2 2025 Holdings

Filed 2025-08-12 | 9 holdings | $72.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Actuate Therapeutics Inc(ACTU)COM005083100$60.9M9,965,07983.9%
Opus Genetics Inc(IRD)COM67577R102$3.5M3,683,4294.8%
Lantern Pharma Inc(LTRN)COM51654W101$3.4M1,075,9524.7%
Rein Therapeutics Inc(RNTX)COM NEW00887A204$2.4M1,690,7513.3%
Cognition Therapeutics Inc(CGTX)COM19243B102$1.9M6,000,0002.6%
In8bio IncCOM45674E109$599.1K286,6640.8%